Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

CONTEXT Infections caused by ceftazidime sodium-resistant gram-negative bacteria that harbor extended-spectrum beta-lactamases (ESBLs) are increasing in frequency in hospitals in the United States. OBJECTIVES To report a citywide nursing home-centered outbreak of infections caused by ESBL-producing gram-negative bacilli and to describe the clinical and molecular epidemiology of the outbreak. DESIGN Hospital-based case-control study and a nursing home point-prevalence survey. Molecular epidemiological techniques were applied to resistant strains. SETTINGS A 400-bed tertiary care hospital and a community nursing home. PATIENTS Patients who were infected and/or colonized with ceftazidime-resistant Escherichia coli, Klebsiella pneumoniae, or both and controls who were admitted from nursing homes between November 1990 and July 1992. MAIN OUTCOME MEASURES Clinical and epidemiological factors associated with colonization or infection by ceftazidime-resistant E coli or K pneumoniae; molecular genetic characteristics of plasmid-mediated ceftazidime resistance. RESULTS Between November 1990 and October 1992, 55 hospital patients infected or colonized with ceftazidime-resistant E coli, K pneumoniae, or both were identified. Of the 35 admitted from 8 nursing homes, 31 harbored the resistant strain on admission. All strains were resistant to ceftazidime, gentamicin, and tobramycin; 96% were resistant to trimethoprim-sulfamethoxazole and 41% to ciprofloxacin hydrochloride. In a case-control study, 24 nursing home patients colonized with resistant strains on hospital admission were compared with 16 nursing home patients who were not colonized on hospital admission; independent risk factors for colonization included poor functional level, presence of a gastrostomy tube or decubitus ulcers, and prior receipt of ciprofloxacin and/or trimethoprim-sulfamethoxazole. In a nursing home point-prevalence survey, 18 of 39 patients were colonized with ceftazidime-resistant E coli; prior receipt of ciprofloxacin or trimethoprim-sulfamethoxazole and presence of a gastrostomy tube were independent predictors of resistance. Plasmid studies on isolates from 20 hospital and nursing home patients revealed that 17 had a common 54-kilobase plasmid, which conferred ceftazidime resistance via the ESBL TEM-10, and mediated resistance to trimethoprim-sulfamethoxazole, gentamicin, and tobramycin; all 20 isolates harbored this ESBL. Molecular fingerprinting showed 7 different strain types of resistant K pneumoniae and E coli distributed among the nursing homes. CONCLUSIONS Nursing home patients may be an important reservoir of ESBL-containing multiple antibiotic-resistant E coli and K pneumoniae. Widespread dissemination of a predominant antibiotic resistance plasmid has occurred. Use of broad-spectrum oral antibiotics and probably poor infection control practices may facilitate spread of this plasmid-mediated resistance. Nursing homes should monitor and control antibiotic use and regularly survey antibiotic resistance patterns among pathogens.

[1]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[2]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[3]  V. Jarlier,et al.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. , 1988, Reviews of infectious diseases.

[4]  S. Levy.  The Antibiotic Paradox , 1992, Springer US.

[5]  K. Bush,et al.  Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate , 1994, Antimicrobial Agents and Chemotherapy.

[6]  G. Gerbaud,et al.  Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. , 1988, Reviews of infectious diseases.

[7]  R A Weinstein,et al.  Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. , 1996, JAMA.

[8]  G. Papanicolaou,et al.  Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility , 1990, Antimicrobial Agents and Chemotherapy.

[9]  S. B. Singer,et al.  Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients , 1992, Antimicrobial Agents and Chemotherapy.

[10]  R. Reichley,et al.  In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins , 1995, Antimicrobial agents and chemotherapy.

[11]  I. Stemplinger,et al.  Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transfer , 1996, Journal of clinical microbiology.

[12]  G. Papanicolaou,et al.  Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae , 1990, Antimicrobial Agents and Chemotherapy.

[13]  A. Darfeuille‐Michaud,et al.  Relationship between adhesion to intestinal Caco-2 cells and multidrug resistance in Klebsiella pneumoniae clinical isolates , 1997, Journal of clinical microbiology.

[14]  R A Weinstein,et al.  Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. , 1996, The Journal of infectious diseases.

[15]  K. Bush,et al.  Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae , 1994, Antimicrobial Agents and Chemotherapy.

[16]  G. Bourg,et al.  Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital , 1994, Journal of clinical microbiology.

[17]  J. Allignet,et al.  Conjugative transfer of staphylococcal antibiotic resistance markers in the absence of detectable plasmid DNA , 1986, Antimicrobial Agents and Chemotherapy.

[18]  J. Heritage,et al.  Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. , 1997, The Journal of antimicrobial chemotherapy.

[19]  T. Liesegang.  Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes , 1998 .

[20]  P. Courvalin,et al.  Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase , 1990, Antimicrobial Agents and Chemotherapy.

[21]  J. Carlet,et al.  Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors , 1988, Antimicrobial Agents and Chemotherapy.

[22]  B. Finlay,et al.  Enteropathogenic E. coli (EPEC) Transfers Its Receptor for Intimate Adherence into Mammalian Cells , 1997, Cell.

[23]  C L Emery,et al.  Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center , 1997, Journal of clinical microbiology.

[24]  P. Desjardins,et al.  Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital , 1993, Journal of clinical microbiology.

[25]  I. Wachsmuth,et al.  Resistance Plasmid Transfer by Serratia marcescens in Urine , 1977, Antimicrobial Agents and Chemotherapy.

[26]  A. Medeiros,et al.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  H. Birnboim,et al.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA. , 1979, Nucleic acids research.

[28]  P. Coudron,et al.  Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find , 1997, Journal of clinical microbiology.

[29]  G. Jacoby,et al.  Quinolone resistance from a transferable plasmid , 1998, The Lancet.

[30]  J. Quinn,et al.  Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae , 1989, Antimicrobial Agents and Chemotherapy.

[31]  P. Lagrange,et al.  Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals , 1994, Journal of clinical microbiology.

[32]  Benjamin Schwartz,et al.  Handwashing and glove use in a long-term-care facility--Maryland, 1992. , 1997, MMWR. Morbidity and mortality weekly report.

[33]  J. Quinn,et al.  Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences , 1993, Antimicrobial Agents and Chemotherapy.

[34]  K S Meyer,et al.  Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins , 1993, Annals of Internal Medicine.

[35]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[36]  G. Weinstock,et al.  Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites , 1990, Journal of clinical microbiology.

[37]  R. Weinstein,et al.  Strategies for prevention and control of multiple drug-resistant nosocomial infection. , 1981, The American journal of medicine.

[38]  Patrick Legrand,et al.  TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAE , 1987, The Lancet.